首页> Haematologica> A B-cell receptor-related gene signature predicts response to ibrutinib treatment in mantle cell lymphoma cell lines.

A B-cell receptor-related gene signature predicts response to ibrutinib treatment in mantle cell lymphoma cell lines.

导出 OA

翻译打印收藏纠错

第一作者： Tiziana,D'Agaro

第一单位： Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano.

作者： Tiziana,D'Agaro ^[1] ; Antonella,Zucchetto ^[1] ; Filippo,Vit ^[2] ; Tamara,Bittolo ^[1] ; Erika,Tissino ^[1] ; Francesca Maria,Rossi ^[1] ; Massimo,Degan ^[1] ; Francesco,Zaja ^[3] ; Pietro,Bulian ^[1] ; Michele Dal,Bo ^[1] ; Simone,Ferrero ^[4] ; Marco,Ladetto ^[5] ; Alberto,Zamò ^[6] ; Valter,Gattei ^[1] ; Riccardo,Bomben ^[7]

作者单位： Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano. ^[1] Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano.;Department of Life Science, University of Trieste, Trieste. ^[2] Department of Internal Medicine and Haematology, Maggiore General Hospital, University of Trieste, Trieste. ^[3] Department of Molecular Biotechnologies and Health Sciences, Hematology Division 1, University of Torino, Torino.;Hematology Division 1, AOU "Città della Salute e della Scienza di Torino" University-Hospital, Torino. ^[4] Department of Molecular Biotechnologies and Health Sciences, Hematology Division 1, University of Torino, Torino.;SC Ematologia Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo, Alessandria. ^[5] Department of Oncology, University of Torino, Torino, Italy. ^[6] Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano rbomben@cro.it. ^[7]